Clinical Trials on Exocrine Pancreatic Insufficiency: Cystic Fibrosis in Belgium

Total 246 results

Forest Laboratories

Completed

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Exocrine Pancreatic Insufficiency: Cystic Fibrosis

United Kingdom, Italy, Belgium, Bulgaria, France, Germany, Poland
Chiesi Farmaceutici S.p.A.

Completed

A Study to Investigate Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of CHF6333 in Healthy Subjects (CHF6333 FIH)

Cystic Fibrosis | Non-Cystic Fibrosis Bronchiectasis

Belgium
University Hospital St Luc, Brussels
KU Leuven

Withdrawn

Long Term Significance (Survival) of LCI in Patients With Cystic Fibrosis

Cystic Fibrosis (CF)

Belgium
Cliniques universitaires Saint-Luc- Université...
Université de Liège

Recruiting

New Markers of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Function in Sweat

Cystic Fibrosis | Biomarkers

Belgium
University Hospital, Antwerp

Active, not recruiting

Airway Microbiome of Cystic Fibrosis Patients

Cystic Fibrosis

Belgium
Queen Fabiola Children's University Hospital

Completed

Omega 3 Supplementation in Cystic Fibrosis Patients

Cystic Fibrosis

Belgium
University Hospital, Ghent
Belgian Society against Cystic Fibrosis

Completed

Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients With Cystic Fibrosis

Cystic Fibrosis

Belgium
University Hospital, Ghent

Completed

Can Quantitative Ultrasound be Used for the Evaluation of Bone Health in Adolescents and Adults With Cystic Fibrosis

Cystic Fibrosis

Belgium
University Hospital, Ghent
Scientific research fund Bruges

Completed

Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group

Cystic Fibrosis

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Efficacy of a New Sweat Collection Support: Impact on Neonatal Screening and Early Treatment of Cystic Fibrosis (MACRODUCT-3710)

Cystic Fibrosis

Belgium
Cliniques universitaires Saint-Luc- Université...

Unknown

Effects of AD on VI in Patients With CF

Cystic Fibrosis

Belgium
Queen Fabiola Children's University Hospital

Unknown

Epidemiology of the Nasal Flora at the Reference Center for Cystic Fibrosis of Queen Fabiola Children's University Hospital. (FLONAMUC)

Cystic Fibrosis

Belgium
Galapagos NV

Completed

Pharmacokinetics of GLPG2737 in Male Subjects With Cystic Fibrosis

Cystic Fibrosis

Belgium
University Hospital, Antwerp

Terminated

Functional Respiratory Imaging and Orkambi in CF

Cystic Fibrosis

Belgium
Cliniques universitaires Saint-Luc- Université...

Terminated

Does a Nasal Instillation of Vardenafil Normalize the Nasal Potential Difference in Cystic Fibrosis Patients?

Cystic Fibrosis

Belgium
Galapagos NV

Completed

Pharmacokinetics of GLPG3067 in Male Subjects With Cystic Fibrosis.

Cystic Fibrosis

Belgium
Cliniques universitaires Saint-Luc- Université...

Unknown

Impaired Secretory IgA and Mucosal Immunity in Cystic Fibrosis (Forton2015)

Cystic Fibrosis

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis Adults

Healthy | Cystic Fibrosis

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis Children

Healthy | Cystic Fibrosis

Belgium
Actelion

Completed

Miglustat in Cystic Fibrosis

Cystic Fibrosis

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Does a Nasal Instillation of Miglustat Normalize the Nasal Potential Difference in Cystic Fibrosis Patients ?

Cystic Fibrosis

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Comparison of 2 Treatment Regimens for Eradication of P Aeruginosa Infection in Children With Cystic Fibrosis (CCTOBI)

Cystic Fibrosis

Belgium
University Hospital, Ghent

Terminated

Influence of a Residential Rehabilitation Program on Body Composition in Patients With Cystic Fibrosis

Cystic Fibrosis

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Sputum Purulence as a Predictor of Cystic Fibrosis Exacerbations: a Prospective Cohort Trial. (MucoSpuCo)

Cystic Fibrosis

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Effects of SIMEOX on Airway Clearance in Cystic Fibrosis

Cystic Fibrosis

Belgium
University Ghent
King Baudouin Foundation; Belgische Vereniging voor Strijd tegen Mucoviscidose

Terminated

LC-MS/MS Based Method Development for the Monitoring of Antibiotic Concentrations in Sputum of Cystic Fibrosis Patients

Cystic Fibrosis

Belgium
University Hospital, Ghent

Completed

Evaluation of Salt Status in Patients With Cystic Fibrosis

Cystic Fibrosis | Salt; Deficit (or Low)

Belgium
CHC MontLégia

Active, not recruiting

Daily Monitoring of Respiratory Symptoms and Spirometry During ETI Treatment in Persons With Cystic Fibrosis.

Cystic Fibrosis

Belgium
Galapagos NV

Completed

Study of GLPG1837 in Subjects With Cystic Fibrosis (S1251N Mutation) (SAPHIRA2)

Cystic Fibrosis

Belgium, Netherlands
University Hospital, Antwerp

Enrolling by invitation

Viral Infections and Airway Microbiome in Young Children With Cystic Fibrosis

Respiratory Viral Infection | Respiratory Morbidity | Cystic Fibrosis in Children | Respiratory Bacterial Infection | Inflammation Lungs

Belgium
Hill-Rom

Completed

Evaluation of an Airway Clearance System

Cystic Fibrosis

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Evaluation of the Timing of the Nebulization Related to the Physiotherapy Session

Cystic Fibrosis

Belgium
University Hospital, Ghent
BVSM

Terminated

The Effect of Inhaled N-Acetylcysteine Compared to Normal Saline on Sputum Rheology and Lung Function

Cystic Fibrosis

Belgium
Cliniques universitaires Saint-Luc- Université...

Unknown

Comparison of Amikacin Lung Delivery With Two Nebulizers

Healthy | Cystic Fibrosis

Belgium
Cliniques universitaires Saint-Luc- Université...

Unknown

Evaluation of Nebulization and Positive Expiratory Pressure Combination

Cystic Fibrosis | Healthy Subjects

Belgium
AbbVie

Terminated

Study to Evaluate Adverse Events and Change in Disease Activity With Oral Capsules of Galicaftor/Navocaftor/ABBV-119 or Galicaftor/Navocaftor/ABBV-576 Combination Therapies in Adult Participants With Cystic Fibrosis

Cystic Fibrosis (CF)

United States, Australia, Belgium, Hungary, Netherlands, New Zealand, Slovakia, United Kingdom
PTC Therapeutics

Completed

A Study of Ataluren in Pediatric Participants With Cystic Fibrosis

Cystic Fibrosis

France, Belgium
ProQR Therapeutics
European Commission

Completed

Exploratory Study to Evaluate QR-010 in Subjects With Cystic Fibrosis ΔF508 CFTR Mutation

Cystic Fibrosis

United States, France, Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Mortality in Non-cystic Fibrosis Bronchiectasis

Non-cystic Fibrosis Bronchiectasis

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

1STST and Muscle Weakness in CF Patients

Cystic Fibrosis

Belgium
Cliniques universitaires Saint-Luc- Université...

Recruiting

Implementation of a Non-invasive Version of the Imaging β-adrenergic-dependent Sweat Secretion Test (BUBBLE TEST)

Mucoviscidosis Involving the Lung

Belgium
Universitaire Ziekenhuizen KU Leuven
B. Braun Medical SA

Completed

PREMO Study: to Investigate Port REMoval Outcomes (PREMO)

Neoplasms | Cystic Fibrosis

Belgium
Proteostasis Therapeutics, Inc.

Completed

Study Designed to Assess the Safety, Tolerability and PK of PTI-808 in Healthy Volunteers and in Adults With Cystic Fibrosis

Healthy Volunteer - Complete | Cystic Fibrosis - Complete

United States, Belgium, United Kingdom, France, Germany, Canada, Denmark, New Zealand, Australia
Insmed Incorporated

Completed

Multidose Safety and Tolerability Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKACE™)

Cystic Fibrosis

Poland, Ukraine, Serbia, Belgium, Hungary, Slovakia, North Macedonia
Universitaire Ziekenhuizen KU Leuven

Completed

Vaccination Coverage and Level of Protection in Patients at Risk

Diabetes | Allergy | Chronic Kidney Disease | Cystic Fibrosis | Heart Disease

Belgium
Vertex Pharmaceuticals Incorporated

Completed

A Study to Evaluate ELX/TEZ/IVA on Cough and Physical Activity in Participants With Cystic Fibrosis (CF)

Cystic Fibrosis

Belgium, Spain, Australia, Canada
Insmed Incorporated

Completed

Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) - Extension Phase

Cystic Fibrosis

Poland, Ukraine, Serbia, Belgium, Hungary, Slovakia, North Macedonia
Vertex Pharmaceuticals Incorporated

Completed

A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation (TRANSPORT)

Cystic Fibrosis, Homozygous for the F508del CFTR Mutation

United States, France, Spain, Belgium, Canada, Austria, Australia, Germany, United Kingdom, Denmark
Queen Fabiola Children's University Hospital
Centre National de Référence S.aureus

Unknown

Cross Transmissions of Pseudomonas Aeruginosa Between Children From a Same Cystic Fibrosis Center. (PAPED)

Cross Infection | Cystic Fibrosis | Pseudomonas Aeruginosa

Belgium
Bayer
Merck Sharp & Dohme LLC

Terminated

Early Signs of Efficacy Study With Riociguat in Adult Homozygous Delta F508 Cystic Fibrosis Patients

Cystic Fibrosis

Germany, United States, France, Canada, Belgium, Netherlands, United Kingdom

Clinical Trials on Exocrine Pancreatic Insufficiency: Cystic Fibrosis in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations